3個のマウス実験モデルで解析したテトラスパニンCD9の変形性関節症における役割 by Sumiyoshi, Norihiko
Biomedical Research (Tokyo) 37 (5) 283–291, 2016
The role of tetraspanin CD9 in osteoarthritis using three different mouse 
models
Norihiko SUMIYOSHI1*, Hiroyuki ISHITOBI2, 3*, Shigeru MIYAKI1, 2, Kenji MIYADO4, Nobuo ADACHI1, and Mitsuo 
OCHI1
1 Department of Orthopaedic Surgery, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Hiroshima 734-
8551, Japan; 2 Department of Regenerative Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Hiroshima 734-8551, Japan; 
3 Research Fellow of the Japan Society for the Promotion of Science, Japan; and 4 Department of Reproductive Biology, National Center 
for Child Health and Development, Tokyo, Japan
(Received 21 June 2016; and accepted 15 August 2016)
ABSTRACT
Although osteoarthritis (OA) is the most prevalent aging-related joint disease, the understanding 
of mechanisms of OA pathogenesis remains limited. Key features include the progressive degrada-
tion of articular cartilage, synovial hyperplasia, and angiogenesis in joint tissues. CD9, a member 
of the tetraspanin family, is localized in the cell membranes and partly in the endosomes of all 
mammalian cell types. CD9 is associated with inflammation and angiogenesis through cell adhe-
sion, migration, and signal transduction. This study examined the role of CD9 in OA development 
in three different mouse models: an aging model, a surgical model and antigen-induced arthritis 
(AIA) model, using CD9 deficient mice. Our study showed that CD9 deficiency reduced the se-
verity of hallmarks of OA including cartilage degradation and soft tissue inflammation in aged 
mice. In the AIA model, cartilage damage and inflammation were also reduced in CD9−/− mice. 
This was in contrast to the surgical OA model where disease severity was similar in wild-type and 
CD9−/− mice. Col2a1 and Aggrecan expression was increased in chondrocytes of CD9−/− mice 
compared with those of wild-type mice. Our results indicate that the suppression of cartilage deg-
radation in CD9−/− could be in part related to an increase in the expression of the two main carti-
lage extracellular matrix proteins aggrecan and type II collagen.
Key pathological features of all forms of arthritis in-
clude joint inflammation with infiltration of leuko-
cytes in the synovium, causing joint tissue remodeling 
and destruction. Osteoarthritis (OA) is the most prev-
alent joint disease. It is characterized by degradation 
of articular cartilage and alterations in other joint 
tissues such as subchondral bone and the synovium. 
The critical risk factors are aging, trauma and in-
flammation, and these factors impair the homeostasis 
of joint tissues through dysregulation of intracellular 
signaling. The understanding of the mechanisms of 
OA pathogenesis remains limited (22).
　CD9 is localized in the cell membranes and partly 
in the endosomes of all types of mammalian cells. It 
is a four membrane-spanning protein and a member 
of the tetraspanin family, which also includes CD63, 
CD81, CD82, and CD151. However, CD9 has unique 
functions in angiogenesis through cell adhesion, mi-
gration, and signal transduction, and it is involved 
in cell fusion processes linked to fertilization, osteo-
clastogenesis and myogenesis (2, 7, 9, 12, 15, 20, 
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indicated severe change (29).
Quantitative real-time polymerase chain reaction. 
Articular chondrocytes were isolated from 1-month 
old wild-type mice and CD9−/− mice (25). They were 
seeded at 5 × 104 cells/well on 24 well plates, and 
with 1 ng/mL interleukin-1β (IL-1β) (WAKO, Osaka, 
Japan) for an additional 24 h. Total RNA was extract-
ed from chondrocytes using TRIzol Reagent (Thermo 
Fisher Scientific, Waltham, MA, USA). Complemen-
tary DNA (cDNA) was synthesized using 500 ng of 
total RNA with the SuperScript VILO cDNA Syn-
thesis Kit (Thermo Fisher Scientific). TaqMan Gene 
Expression Assay probes (Life Technologies) were 
used to detect Col2a1 (Mm01309565_m1), Acan 
(Mm00545807), Mmp-13 (Mm01168713), Adamts-5 
(Mm01344182_m1). Gapdh (Mm99999915_g1) was 
used as the internal control to normalize the sample 
differences. The ΔΔCt method was used to analyze 
the real-time PCR data.
Proteoglycan release assay. Femoral heads were 
harvested from 4-week old wild type mice and incu-
bated at 37°C for 72 h in 48 well plates. Each well 
contained 500 μL of DMEM with 10% FBS and 1% 
penicillin/streptomycin. The cartilage samples were 
washed 3 times, and cultured at 37°C for an addi-
tional 72 h in 500 μL of serum-free DMEM with IL-
1β (1 ng/mL) or without IL-1β. The assay was 
performed on least 3 independent experiments with 
duplicate wells. The concentration of the released 
glycosaminoglycan in the conditioned cartilage me-
dium was measured using the Blyscan Glycosami-
noglycan assay kit (Biocolor; County Antrim, UK) 
per the manufacturer’s protocol.
Immunohistochemical analysis. Knee joint sections 
were immunostained with anti-alpha-smooth muscle 
Actin antibody (Abcam, Austin, TX, USA, ab5694; 
1 : 200) and anti-ADAMTS-5 antibody (Abcam, 
ab52947; 1 : 75), using Vectastain ABC-AP alkaline 
phosphatase (Vector Laboratories, Burlingame, CA, 
USA) as described previously (1), and with anti-
MMP-13 antibody (Abgent, AP1801a; 1 : 100), using 
3,3’-diaminobenzidine (DAB) substrate as described 
previously (25).
Statistical analysis. The data were analyzed by the 
Mann-Whitney U test, Steel or Steel-Dwass. Differ-
ences were considered statistically significant at * = 
P < 0.05 and ** = P < 0.01.
21, 24, 30). Furthermore, it was recently reported 
that CD9−/− mice developed both enhanced macro-
phage infiltration and TNF-α production in the lungs 
after intranasal administration of lipopolysaccharide 
(LPS) (23), while the up-regulation of CD9 de-
creased lung inflammation in mice (10). Regarding 
arthritis, previous reports have shown that CD9 is 
abundantly expressed in the OA synovium (14), in 
activated osteoclasts in osteoporosis, and in the sites 
of bone erosion in arthritic lesions of collagen-in-
duced arthritis (8). However, the role of tetraspanins 
in OA pathogenesis remains unclear. The purpose of 
this study is to examine the OA development in 
CD9−/− mice using three different mouse models of 
arthritis: an aging model of primary OA, a surgical 
model of posttraumatic OA, and antigen-induced ar-
thritis (AIA) as a transient inflammation model.
MATERIALS AND METHODS
Mice and arthritis models. CD9−/− mice on a C57BL/6J 
background have been described previously (16). All 
animal experiments were performed according to 
protocols approved by the Hiroshima University Ani-
mal Care and Use Committee. Male mice were used 
in the joint analysis in the aging model. Knee joints 
were evaluated histologically at 6 months (wild-type: 
n = 9, CD9−/−: n = 10) and at 22 months (wild-type: 
n = 11, CD9−/−: n = 8), in order to monitor spontane-
ous age-related OA. Experimental OA was induced 
by transecting the medial meniscotibial ligament and 
the medial collateral ligament in the right knees of 
wild-type mice (n = 8) and CD9−/− mice (n = 8) (3, 
11). Female mice were used in the AIA model. AIA 
was induced in the knee joints of 10-week old wild-
type mice (n = 19) and CD9−/− mice (n = 19) by in-
tra-articular injection of methylated bovine serum 
albumin (mBSA) (Sigma-Aldrich, St. Louis, MO, 
USA) (17).
Histological assessment of the knee joints. The knee 
joints were embedded in paraffin after fixation and 
decalcification. Sagittal sections of the knee joints of 
wild-type mice and CD9−/− mice were stained with 
Safranin O/Fast Green (Sigma) for histopathological 
analysis. The severity of cartilage degeneration in 
aging and surgical models was evaluated using the 
OARSI scoring system (4). The severity of inflam-
mation in all models was evaluated using five pa-
rameters: synovitis, joint space exudate, soft tissue 
inflammation, cartilage degradation, and bone dam-
age. For each parameter, a score of 0 indicated 
none, 1 indicated mild, 2 indicated moderate, and 3 
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age, OA severity in wild-type mice ranged from min-
imal changes to cartilage fibrillation or partial and 
full thickness defects with exposure of subchondral 
bone (Fig. 1A). These changes were less severe in 
CD9−/− mice (Fig. 1A), and the OARSI score indi-
cated significantly decreased severity of OA in the 
CD9−/− mice compared with that in the wild-type 
mice (Fig. 1B). In the inflammation scores, synovi-
tis, soft tissue inflammation and bone damage in the 
knee joint were less severe in the CD9−/− mice, and 
RESULTS
Age-related OA in CD9−/− mice
To reveal whether CD9 is involved in the develop-
ment of OA with aging, we examined the knee joints 
of wild-type and CD9−/− mice at 6- and 22-months. 
CD9−/− mice exhibited normal skeletal development. 
From 1 to 6 months of age, both strains of mice 
showed intact articular cartilage and similar proteo-
glycan staining (data not shown). At 22 months of 
Fig. 1　CD9−/− mice exhibit reduced severity of OA in aged 22-month old mice. A. Knee joints from 22-month old wild-type 
and CD9−/− mice were collected, and the sections were assessed by Safranin O/Fast Green staining. Scale Bars = 200 μm. 
These samples exhibited thickness defect of cartilage (arrow), cartilage fibrillation (arrowhead), loss of Safranin O (asterisk). 
These changes were less severe in CD9−/− mice. B. Histological assessment using OARSI scoring system of spontaneous 
cartilage degeneration exacerbated with aging in wild-type mice and CD9−/− mice. C. Histological assessment using inflam-
matory scoring system in mice at 22 months old, including 5 parameters: synovitis, joint space exudate, soft tissue inflam-
mation, cartilage degradation, and bone damage. D. Total score of 5 inflammatory parameters. Values are the mean ± SD. 
Statistical analysis was performed with the Mann-Whitney U test. * = P < 0.05 versus wild-type mice.
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brillation, vertical clefts and erosion with sclerosis 
of subchondral bone were observed in similar pat-
terns in both wild-type and CD9−/− mice at 12 weeks 
after surgery (Fig. 2A). However, the OARSI score 
(Fig. 2B) and inflammation score (synovitis, joint 
space exudate, soft tissue inflammation, cartilage 
degradation, and bone damage) were not significant-
ly different between the wild-type and CD9−/− mice 
(Fig. 2C, D).
the total inflammation score was also decreased in 
the CD9−/− mice (Fig. 1C, D).
Surgical posttraumatic OA model
A surgical model of posttraumatic OA was generated 
in 10-week-old wild-type and CD9−/− mice by tran-
secting the medial meniscotibial ligament and the 
medial collateral ligament. In this model, OA-like 
changes such as loss of safranin-O or cartilage fi-
Fig. 2　Histological assessment in knee joints of mice with surgical OA. A. Knee joints from wild-type and CD9−/− mice with 
surgical OA were collected and the sections were assessed by Safranin O/Fast Green staining. Scale Bars = 200 μm. B. 
Histological assessment using OARSI scoring system of spontaneous cartilage degeneration in wild-type mice and CD9−/− 
mice. C. Histological assessment using inflammatory scoring system in 10-week old mice, including 5 parameters: synovitis, 
joint space exudate, soft tissue inflammation, cartilage degradation and bone damage. D. Total score of 5 inflammatory pa-
rameters. Values are the mean ± SD. Statistical analysis was performed using the Mann-Whitney U test.
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Fig. 3　Histological assessment of knee joints in the AIA model. A. Knee joints from wild-type and CD9−/− mice of AIA mod-
el were collected, and the sections were assessed by H-E staining. In both wild-type and CD9−/− mice, synovial hyperplasia 
was exhibited. (a) Scale Bars = 300 μm. (b) Scale Bars = 200 μm B. Photographs of a knee from AIA mouse model focused 
on the difference in degree of cartilage degradation (arrow) between the wild-type and CD9−/− mouse. Scale Bars = 200 μm.
C. Photographs of a knee from AIA mouse model focused on the difference in degree of joint space exudate (arrowhead) 
between the wild-type and CD9−/− mouse. Scale Bars = 100 μm. D. Histological assessment using the inflammatory scoring 
system in 10-week old mice, including 5 parameters. Values are the mean ± SD. Statistical analysis was performed using 
the Mann-Whitney U test. * = P < 0.05 versus wild-type mice. E. Knee joints from wild-type mice and CD9−/− mice were ana-
lyzed by immunohistochemistry for ADAMTS-5 and MMP-13. Total numbers of ADAMTS-5 and MMP-13 positive cells in six 
fields were counted, and the percentage of positive cells was calculated. Values are the mean ± SD. Statistical analysis was 
performed with the Mann-Whitney U test. * = P < 0.05 versus wild-type mice. Scale Bars = 200 μm.
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Inflammatory arthritis model
We further examined the role of CD9 in the AIA 
model. Inflammatory arthritis signs such as synovial 
hyperplasia (Fig. 3A), and proteoglycan loss (Fig. 3B) 
were exhibited in both the wild-type and CD9−/− 
mice. The scores for synovitis, soft tissue inflamma-
tion and bone damage were not significantly different 
between the wild-type and CD9−/− mice (Fig. 3D). 
However, the cartilage degeneration (Fig. 3B), joint 
space exudate of leukocytes (Fig. 3C), and the total 
score for AIA were significantly lower in the CD9−/− 
mice than in the wild-type mice (Fig. 3D). The ex-
pression of ADAMTS-5 and MMP-13, main cartilage 
degradation enzymes, was characterized by immuno-
histochemistry in the articular cartilage of mice with 
AIA. Although ADAMTS-5 was not significantly dif-
ferent, the number of MMP-13 positive chondrocytes 
was significantly lower in the CD9−/− mice than in 
the wild-type mice (Fig. 3E).
Effect of CD9 deficiency on articular chondrocytes
IL-1β is one of the critical mediators driving the in-
flammatory process which leads to OA pathogenesis. 
To determine whether CD9 in cartilage is important 
for the degradation of the cartilage-related matrix, 
we quantified proteoglycan release from mouse fem-
oral head cartilage explants. Cartilage explants from 
wild-type and CD9−/− mice treated with IL-1β showed 
significantly increased proteoglycan release. Howev-
er, it was not significantly different between the wild-
type and CD9−/− mice with or without IL-1β (Fig. 4A). 
Adamts-5 mRNA levels with or without IL-1 treat-
ment were also not significantly different between 
wild-type and CD9−/− chondrocytes (Fig. 4B). Al-
though there was a trend towards reduced Mmp-13 in 
IL-1β treated CD9−/− chondrocytes, this difference was 
not statistically significant from wild type chondro-
cytes (Fig. 4B). The levels of cartilage matrix genes 
Col2a1 and Aggrecan in control were significantly 
higher in CD9−/− chondrocytes than in wild-type 
chondrocytes. In response to IL-1β stimulation, the 
levels of Col2a1 and Aggrecan were significantly re-
duced in wild-type and CD9−/− chondrocytes but even 
under IL-1 treatment remained higher in CD9−/− 
chondrocytes (Fig. 4B).
DISCUSSION
This is the first study to demonstrate a role of CD9 
in OA development in three different animal mod-
els. CD9 deficiency did not lead to apparent abnor-
malities in joint development and joints of CD9−/− 
mice were completely normal on histological analysis 
at 6 months. However, intra-articular inflammation 
and cartilage degeneration during aging was attenu-
ated in the CD9−/− mice compared with the wild-type 
mice. Our study also showed CD9 deficiency had 
certain protective effects in the AIA model where it 
reduced the severity of cartilage degradation, some 
inflammation markers and the total AIA score. By 
contrast, the severity of the surgical OA model was 
not significantly different between wild-type and 
CD9−/− mice. Thus CD9 deficiency has certain pro-
tective effect in the aging and AIA models but not 
in the surgical model. This difference among the 
three models could be due to the fact that the surgi-
cal model is much more severe than the two other 
models. The profound joint instability caused by 
transection of the meniscotibial and the medial col-
lateral ligaments may override potential protective 
effects of CD9 deletion in this model.
　Previous research in macrophages suggested anti-
inflammatory properties of CD9. Statins exert anti-
inflammatory effects by up-regulating CD9 in 
macrophages, and the up-regulation decreases lung 
inflammation in mice (10). However, CD9 expression 
is up-regulated in the synovium of OA (14), and we 
also demonstrated an increase in CD9 expression by 
synovial fibroblasts with IL-1β stimulation, while 
CD9 expression was significantly decreased in chon-
drocytes with IL-1β (Supplemental Figure). Two re-
search groups analyzed the effects of statins on OA 
using the STR/Ort spontaneous OA mouse model 
(28, 31), but observed divergent results.
　In the present study, cartilage degradation was 
significantly reduced in CD9−/− mice in aging and in 
the AIA model. Thus we compared chondrocytes 
from CD9−/− and wild-type mice. Col2a1 and Aggre-
can expression was increased in chondrocytes of 
CD9−/− mice compared with wild-type mice. IL-1β-
induced proteoglycan release from cartilage explants, 
and Adamts-5 and Mmp-13 expression were not sig-
nificantly different between CD9−/− and wild-type 
chondrocytes. Thus, these results suggest that the 
suppression of cartilage degradation in CD9−/− could 
be in part related to an increase in the expression of 
the two main cartilage extracellular matrix proteins 
aggrecan and type II collagen.
　Synovial fibroblasts proliferate, and macrophages 
migrate into OA synoviums. These cells are associ-
ated with cartilage degradation through their release 
of inflammatory cytokines and cartilage degradation 
enzymes (5, 32). CD9 is well known to be associat-
ed with formation of functional complexes between 
integrin and other family. It is also a characteristic 
marker of and membranous components of microves-
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cells (13). Angiogensis is associated with the pro-
gression of arthritis (6, 15, 18, 27), and angiogene-
sis inhibitor shows potential for use in OA treatment 
(19). CD9 knockdown or CD9−/− mice previously 
showed an antiangiogenic effect (9, 12). CD9−/− mice 
icles such as exosomes. We recently reported that 
exosomes derived from IL-1β-stimulated synovial fi-
broblasts induce OA-like changes to normal chon-
drocytes and cartilage (13). These exosomes also 
induce migration and tube formation in endothelial 
Fig. 4　Effect of CD9 deficiency in articular chondrocytes. A. Femoral head cartilage explants from wild-type mice and 
CD9−/− mice cultured with or without IL-1β. Proteoglycan release into the conditioned medium from cartilage was assayed 
as concentration of glycosaminoglycan (GAG). Data are the mean ± SEM. Comparison of mean values was performed by 
the Steel-Dwass test. B. Articular chondrocytes from wild-type mice and CD9−/− mice were treated with or without IL-1β. 
The expression of OA- and cartilage-related genes was analyzed by real-time PCR. Data are the mean ± SEM. Comparison 
of mean values was performed by the Steel-Dwass test. * = P < 0.01 versus chondrocytes without IL-1β from wild-type mice. 
#
 = P < 0.01 versus chondrocytes with IL-1β from wild-type mice.
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exhibited the attenuation of cartilage degradation in 
the aged mice and in the AIA model mice. These re-
sults might be at least in part mediated by the anti-
angiogenic effect and the dysfunction of exosomes 
through CD9 deficiency.
　The present study showed that CD9 deficiency re-
duces the severity of OA such as cartilage degrada-
tion in aged mice, as well as in AIA transient 
inflammation model mice. Thus, CD9 might have 
potential to open new insight for the mechanism and 
protection of OA.
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CD9 deficiency reduces cartilage degradation
Supplemental Figure　Articular chondrocytes and synovial fibroblasts from wild-type mice were treated with or without IL-
1β. The expression of Cd9 was analyzed by real-time PCR. Data are the means ± SEM. Comparison of mean values was 
performed by the Steel test. *P < 0.01 versus control.
